Literature DB >> 1370354

Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells.

D Resnitzky1, N Tiefenbrun, H Berissi, A Kimchi.   

Abstract

One approach to identify postreceptor molecular events that transduce the negative-growth signals of inhibitory cytokines is to analyze the cytokine-induced modifications in the expression of cell-cycle-controlling genes. Here we report that suppression of phosphorylation of the retinoblastoma gene product (pRb) is a receptor-generated event triggered by interferons and interleukin 6 (IL-6) in hematopoietic cell lines. The conversion of pRb to the underphosphorylated forms occurs concomitantly with the decline in c-myc protein expression and both events precede the G0/G1-phase arrest induced by the cytokines. Loss of IL-6-induced c-myc responses in cells that have been stably transfected with constitutive versions of the c-myc gene abrogates the typical G0/G1-phase arrest but does not prevent the specific dephosphorylation of pRb. Conversely, depletion of protein kinase C from cells interferes with part of the interferon-induced suppression of pRb phosphorylation and relieves the G0/G1-phase cell-cycle block without affecting the extent of c-myc inhibition. None of the cytokines, including transforming growth factor beta, reduce the phosphorylation of pRb in S-phase-blocked cells. In contrast, the other IL-6-induced molecular responses, including the decline in c-myc mRNA levels, are not phase-specific and develop normally in S-phase-blocked cells that are depleted of the underphosphorylated functional forms of pRb. These and the suppression of pRb phosphorylation, which occur independently of each other, and suggest that the development of the interferon- or IL-6-induced G0/G1-specific arrest requires at least these two receptor-generated events.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370354      PMCID: PMC48245          DOI: 10.1073/pnas.89.1.402

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

Review 1.  Tumor suppressor genes.

Authors:  C J Marshall
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

Review 2.  Dissecting the complexity of the nervous system by enhancer detection.

Authors:  H J Bellen; C Wilson; W J Gehring
Journal:  Bioessays       Date:  1990-05       Impact factor: 4.345

3.  Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts.

Authors:  G H Stein; M Beeson; L Gordon
Journal:  Science       Date:  1990-08-10       Impact factor: 47.728

4.  The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T.

Authors:  J W Ludlow; J Shon; J M Pipas; D M Livingston; J A DeCaprio
Journal:  Cell       Date:  1990-02-09       Impact factor: 41.582

5.  TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains.

Authors:  J A Pietenpol; R W Stein; E Moran; P Yaciuk; R Schlegel; R M Lyons; M R Pittelkow; K Münger; P M Howley; H L Moses
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

6.  In vitro phosphorylation of the tumor suppressor gene RB protein by mitosis-specific histone H1 kinase.

Authors:  Y Taya; H Yasuda; M Kamijo; K Nakaya; Y Nakamura; Y Ohba; S Nishimura
Journal:  Biochem Biophys Res Commun       Date:  1989-10-16       Impact factor: 3.575

7.  Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta.

Authors:  R J Coffey; C C Bascom; N J Sipes; R Graves-Deal; B E Weissman; H L Moses
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

8.  Negative regulation of human c-fos expression by the retinoblastoma gene product.

Authors:  P D Robbins; J M Horowitz; R C Mulligan
Journal:  Nature       Date:  1990-08-16       Impact factor: 49.962

9.  Regulation of the product of a possible human cell cycle control gene CDC2Hs in B-cells by alpha-interferon and phorbol ester.

Authors:  N S Thomas
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

10.  Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase.

Authors:  B T Lin; S Gruenwald; A O Morla; W H Lee; J Y Wang
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598

View more
  26 in total

1.  Stem-cell factor regulates the expression of cyclin A and retinoblastoma gene product in the growth and differentiation pathway of human megakaryocytic cells.

Authors:  E Shimizu; Y Takahashi; A Shinohara; Y Yamamoto; S Yoshida; A Yamamoto; S Sone; Y Takaue; T Ogura
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest.

Authors:  N Tiefenbrun; D Melamed; N Levy; D Resnitzky; I Hoffman; S I Reed; A Kimchi
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

3.  p53-mediated cell death: relationship to cell cycle control.

Authors:  E Yonish-Rouach; D Grunwald; S Wilder; A Kimchi; E May; J J Lawrence; P May; M Oren
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

4.  RNA fingerprinting using arbitrarily primed PCR identifies differentially regulated RNAs in mink lung (Mv1Lu) cells growth arrested by transforming growth factor beta 1.

Authors:  D Ralph; M McClelland; J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

5.  An in vitro model for cytogenetic conversion in CML. Interferon-alpha preferentially inhibits the outgrowth of malignant stem cells preserved in long-term culture.

Authors:  J J Cornelissen; R E Ploemacher; B W Wognum; A Borsboom; H C Kluin-Nelemans; A Hagemeijer; B Löwenberg
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

6.  Interferon-alpha down-regulates the interleukin-6 receptor in a human multiple myeloma cell line, U266.

Authors:  J C Anthes; Z Zhan; H Gilchrest; R W Egan; M I Siegel; M M Billah
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

7.  Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells.

Authors:  D Melamed; N Tiefenbrun; A Yarden; A Kimchi
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

Review 8.  Interferon treatment of human malignancies--a short review.

Authors:  S Einhorn; H Strander
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

9.  Okadaic acid, an inhibitor of protein phosphatases 1 and 2A, inhibits induction of acute-phase proteins by interleukin-6 alone or in combination with interleukin-1 in human hepatoma cell lines.

Authors:  M K Ganapathi
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

10.  Activation of NF-kB pathway by virus infection requires Rb expression.

Authors:  Maria A Garcia; Pedro Gallego; Michela Campagna; José González-Santamaría; Gloria Martínez; Laura Marcos-Villar; Anxo Vidal; Mariano Esteban; Carmen Rivas
Journal:  PLoS One       Date:  2009-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.